Behandlung von Patienten mit BRAF-mutiertem metastasiertem kolorektalem Karzinom – Ergebnisse des deutschen Tumorregisters kolorektales Karzinom (TKK) 5. November 2020 Zahn M-O, Dörfel S, Schnell R, Wolf T, Vehling-Kaiser U, Kruggel L, Jänicke M, Wetzel N, Marschner N, 2020 Oncology Research and Treatment. 2020;43 (suppl 4)(158):129 https://www.iomedico.com/wp-content/uploads/2020/11/Zahn_TKK_DGHO2020.mp4 Trifluridine/tipiracil in patients with refractory metastatic colorectal cancer in clinical routine in Germany: Interim results of the non-interventional study TACTIC – Interim results of the non-interventional study TACTIC Schwaner I, Göhler T, Decker T, Grundeis M, Sauer A, Fichter C, Moorahrend E, Kröning H, Lipke J, Kojouharoff G, Frank M, Hogrefe C, Marschner… Weiterlesen What affects the choice of first-line treatment for hormone-receptor-positive, HER2-negative advanced breast cancer? Data from the German research platform OPAL A. Welt, M. Thill, E. Stickeler, M.-O. Zahn, A. Nusch, M. Zaiss, U. Neef, S. Fruehauf, R. Buss-Steidle, V. Hagen, M. Chiabudini, L. Kruggel, M. Weiterlesen